BIOMARIN PHARMACEUTICAL INC Other than Temporary Impairment Losses, Investments
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Other than Temporary Impairment Losses, Investments of $12.65 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-04-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfInvestments · last filed 2023-04-28
- BIOMARIN PHARMACEUTICAL INC other than temporary impairment losses, investments for the quarter ending 2023-03-31 was $12.65M.
- BIOMARIN PHARMACEUTICAL INC other than temporary impairment losses, investments for the quarter ending 2022-03-31 was $0.00.
- BIOMARIN PHARMACEUTICAL INC other than temporary impairment losses, investments for the quarter ending 2010-12-31 was $0.00.
- BIOMARIN PHARMACEUTICAL INC other than temporary impairment losses, investments for the quarter ending 2010-09-30 was $0.00.
- BIOMARIN PHARMACEUTICAL INC other than temporary impairment losses, investments for fiscal 2011 was $0.00.
- BIOMARIN PHARMACEUTICAL INC other than temporary impairment losses, investments for fiscal 2010 was $0.00, a 100.00% decline from fiscal 2009.
- BIOMARIN PHARMACEUTICAL INC other than temporary impairment losses, investments for fiscal 2009 was $5.85M, a 44.18% increase from fiscal 2008.
- BIOMARIN PHARMACEUTICAL INC other than temporary impairment losses, investments for fiscal 2008 was $4.06M.
| Period end | Other than Temporary Impairment Losses, Investments 3 month | Other than Temporary Impairment Losses, Investments 6 month | Other than Temporary Impairment Losses, Investments 9 month | Other than Temporary Impairment Losses, Investments 12 month |
|---|---|---|---|---|
| 2023-03-31 | $12.65M 10-Q · filed 2023-04-28 | |||
| 2022-03-31 | $0.00 10-Q · filed 2023-04-28 | |||
| 2011-12-31 | $0.00 10-K · filed 2012-02-22 | |||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $0.00 derived: sum of 2 quarters · filed 2012-02-22 | $0.00 derived: sum of 3 quarters · filed 2012-02-22 | $0.00 10-K · filed 2012-02-22 |
| 2010-09-30 | $0.00 10-Q · filed 2010-10-29 | $0.00 derived: sum of 2 quarters · filed 2010-10-29 | $0.00 10-Q · filed 2010-10-29 | |
| 2010-06-30 | $0.00 10-Q · filed 2010-08-04 | $0.00 10-Q · filed 2010-08-04 | ||
| 2009-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $0.00 derived: sum of 2 quarters · filed 2012-02-22 | $0.00 derived: sum of 3 quarters · filed 2012-02-22 | $5.85M 10-K · filed 2012-02-22 |
| 2009-09-30 | $0.00 10-Q · filed 2010-10-29 | $0.00 derived: sum of 2 quarters · filed 2010-10-29 | $5.85M 10-Q · filed 2010-10-29 | |
| 2009-06-30 | $0.00 10-Q · filed 2010-08-04 | $5.85M 10-Q · filed 2010-08-04 | ||
| 2008-12-31 | $4.06M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |